LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p/PEG3 axis. Fang W, Xia Y. Anticancer Drugs 2022 Mar 8. pii: 00001813-900000000-98225.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fang W, Xia Y. LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p/PEG3 axis. Anticancer Drugs 2022 Mar 8. pii: 00001813-900000000-98225.
PMID: 35276697